{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:36:02Z","timestamp":1778880962352,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1124\/jpet.109.161075","type":"journal-article","created":{"date-parts":[[2009,11,11]],"date-time":"2009-11-11T04:25:58Z","timestamp":1257913558000},"page":"1121-1126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prehypertensive Preconditioning Improves Adult Antihypertensive and Cardioprotective Treatment"],"prefix":"10.1016","volume":"332","author":[{"given":"Marcus","family":"Baumann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Sollinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Heemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.109.161075_bib1","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1097\/HJH.0b013e3282ef84f8","article-title":"Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage.","volume":"25","author":"Baumann","year":"2007","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.109.161075_bib2","first-page":"207","article-title":"Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age.","volume":"25","author":"Baumann","year":"2007","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.109.161075_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1748-1716.2008.01916.x","article-title":"Renal medullary effects of transient prehypertensive treatment in young spontaneously hypertensive rats.","volume":"196","author":"Baumann","year":"2009","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1124\/jpet.109.161075_bib4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMc061382","article-title":"Treating prehypertension.","volume":"355","author":"Baumann","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.109.161075_bib5","first-page":"S63","article-title":"Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat.","volume":"2","author":"Berecek","year":"1984","journal-title":"J Hypertens Suppl"},{"key":"10.1124\/jpet.109.161075_bib6","first-page":"H543","article-title":"Myocardial tumor necrosis factor-\u03b1 secretion in hypertensive and heart failure-prone rats.","volume":"277","author":"Bergman","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.109.161075_bib7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/00004872-200207000-00029","article-title":"Brief losartan treatment in young spontaneously hypertensive rats abates long-term blood pressure elevation by effects on renal vascular structure.","volume":"20","author":"Bergstr\u00f6m","year":"2002","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.109.161075_bib8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/HYPERTENSIONAHA.108.113357","article-title":"Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988\u20131994 and 1999\u20132004.","volume":"52","author":"Cutler","year":"2008","journal-title":"Hypertension"},{"key":"10.1124\/jpet.109.161075_bib9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMc061382","article-title":"Treating prehypertension.","volume":"355","author":"Grassi","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.109.161075_bib10","doi-asserted-by":"crossref","first-page":"H1775","DOI":"10.1152\/ajpheart.00305.2002","article-title":"Structural, functional, and molecular characterization of the SHHF model of heart failure.","volume":"283","author":"Heyen","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.109.161075_bib11","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa060838","article-title":"Feasibility of treating prehypertension with an angiotensin-receptor blocker.","volume":"354","author":"Julius","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.109.161075_bib12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.HYP.0000062465.60601.CC","article-title":"Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure.","volume":"41","author":"Kacimi","year":"2003","journal-title":"Hypertension"},{"key":"10.1124\/jpet.109.161075_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data.","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"10.1124\/jpet.109.161075_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cardfail.2006.04.006","article-title":"p38 MAP kinase activity is correlated with angiotensin II type 1 receptor blocker-induced left ventricular reverse remodeling in spontaneously hypertensive heart failure rats.","volume":"12","author":"Liang","year":"2006","journal-title":"J Card Fail"},{"key":"10.1124\/jpet.109.161075_bib15","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/HJH.0b013e3282ff8864","article-title":"The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.","volume":"26","author":"L\u00fcders","year":"2008","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.109.161075_bib16","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00109-008-0405-4","article-title":"The A20 gene protects kidneys from ischaemia\/reperfusion injury by suppressing pro-inflammatory activation.","volume":"86","author":"Lutz","year":"2008","journal-title":"J Mol Med"},{"key":"10.1124\/jpet.109.161075_bib17","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.amjhyper.2006.09.014","article-title":"A specialist in clinical hypertension critiques the TROPHY trial.","volume":"19","author":"Meltzer","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1124\/jpet.109.161075_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MNH.0b013e3280c8eebe","article-title":"Treatment options for prehypertension.","volume":"16","author":"Nesbitt","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1124\/jpet.109.161075_bib19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.amjhyper.2006.09.013","article-title":"Studying interventions to prevent the progression from prehypertension to hypertension: does TROPHY win the prize?","volume":"19","author":"Persell","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1124\/jpet.109.161075_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/01.HYP.24.2.205","article-title":"Effect of nifedipine on coronary capillary geometry in normotensive and hypertensive rats.","volume":"24","author":"Rakusan","year":"1994","journal-title":"Hypertension"},{"key":"10.1124\/jpet.109.161075_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00395-003-0401-3","volume":"98","author":"Reffelmann","year":"2003","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/jpet.109.161075_bib22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/HYPERTENSIONAHA.108.117341","article-title":"Effect of olmesartan on tissue expression balance between angiotensin II receptor and its inhibitory binding molecule.","volume":"52","author":"Shigenaga","year":"2008","journal-title":"Hypertension"},{"key":"10.1124\/jpet.109.161075_bib23","doi-asserted-by":"crossref","first-page":"H181","DOI":"10.1152\/ajpheart.00642.2003","article-title":"Long-term left ventricular echocardiographic follow-up of SHR and WKY rats: effects of hypertension and age.","volume":"286","author":"Slama","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.109.161075_bib24","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.febslet.2005.01.068","article-title":"The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy.","volume":"579","author":"Tanaka","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.109.161075_bib25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1751-7176.2008.07837.x","article-title":"An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the trial of preventing hypertension (TROPHY).","volume":"10","author":"Williams","year":"2008","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1124\/jpet.109.161075_bib26","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/01.HYP.23.6.819","article-title":"Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin-converting enzyme inhibitor captopril.","volume":"23","author":"Wu","year":"1994","journal-title":"Hypertension"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524457133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524457133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.109.161075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:07:41Z","timestamp":1740017261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524457133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0022356524457133"],"URL":"https:\/\/doi.org\/10.1124\/jpet.109.161075","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prehypertensive Preconditioning Improves Adult Antihypertensive and Cardioprotective Treatment","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.109.161075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}